I had the privilege to work on the launch of Dupixent with multiple Indications. The iVA (Interactive Visual Aim) was designed for the consumers and narrated by seven patients currently using Dupixent. Their personalized stories convey the benefits of the medicine and have impersonal human connection. I had to lay out the iPad version for the submission, including updating new approved Indications, copy updates and package the project for the submission to MLR. Besides, I had to design print brochures with multiple cover art for different markets; email designs for desktop and mobile and interactive microsites to depict the latest market updates.
